C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/68 (2006.01) C07H 21/04 (2006.01)
Patent
CA 2246487
The present invention relates to a novel DNA assay for the diagnosis and/or prediction of autoimmune diabetes. The present invention relates to a DNA assay for the prediction of autoimmune diabetes in human subjects, which comprises the steps of a) obtaining a DNA sample from the subject and PCR amplification of class III alleles of variable number of tandem repeats (VNTR) located upstream of the insulin gene (INS); and b) electrophoretic co-migration of amplified fragment to identify class III alleles of the insulin VNTR which are identical to S1 or S2, from alleles which differ from S1 and S2; whereby identification of S1 or S2 allele is indicative of at least 1% risk of autoimmune diabetes.
Grabs Rosemarie
Polychronakos Constantin
Vafiadis Petros
Ogilvy Renault
University Mcgill
LandOfFree
Dna assay for the prediction of autoimmune diabetes does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dna assay for the prediction of autoimmune diabetes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dna assay for the prediction of autoimmune diabetes will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1812668